AN EBOLA vaccine has been shown to provide immunity for up to a year in a new Oxford University study.
The findings, based on a clinical trial involving 75 healthy subjects, were published in the Journal of the American Medical Association.
The study was led by the Oxford Vaccine Group at Oxford University.
Dr Matthew Snape, from the university’s Department of Paediatrics, who led the research, said: “This study was conducted in a European population, so it’s important to note that immune responses may differ in a sub-Saharan African population.
“The persistence of vaccine-induced immunity to one year post-immunisation is impressive.”
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here